September 21, 2017 — Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
September 21, 2017
September 21, 2017 — MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 ...
September 21, 2017
September 20, 2017 — Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the ...
September 20, 2017
September 18, 2017 — Corindus Vascular Robotics Inc. announced first patient enrollment in the PRECISION GRX Registry, a ...
September 18, 2017
September 18, 2017 — Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU ...
September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the Journal of the American College of ...
September 18, 2017
September 14, 2017 — Marijuana use is associated with a three-fold risk of death from hypertension, according to ...
September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...
September 14, 2017
September 13, 2017 — Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from ...
September 13, 2017
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
September 13, 2017 — A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results ...
September 13, 2017September 12, 2017 — Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke a ...
September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, according ...
September 12, 2017September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in ...
September 12, 2017
September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively ...
September 12, 2017
September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...
September 12, 2017